Post-approval studies (Phase 4)Study completedNCT00180102
What this trial is testing
AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years
Who this might be right for
Leukemia, Nonlymphocytic, Acute
Technische Universität Dresden 600